Aging human skin shows DNA hypomethylation, which can be reverted by topical melatonin ex vivo
Need to claim your poster? Find the KiKo table at the conference and they'll help
you get set up.
Presented at: Society for Investigative Dermatology 2025
Date: 2025-05-07 00:00:00
Views: 2
Summary: Abstract Body: DNA methylation has emerged as a key mechanism in cell and tissue aging. This involves DNA methyltransferases (DNMTs) that add methyl groups to cytosine, creating 5-methylcytosine (5-mC), which typically silences gene expression. Conversely, ten-eleven-translocation (TET) proteins convert 5-mC to 5-hydroxymethylcytosine (5-hmC), potentially reactivating previously suppressed genes. Our study explores if these epigenetic changes occur during human skin aging ex vivo, using a “speed aging” organ culture assay of aged, full-thickness female scalp skin (4 healthy donors, aged 43-75 yrs). Quantitative immunohistomorphometry revealed that after 3 days, expression levels of DNMT1, 5-mC and 5-hmC in the epidermis were reduced compared to day 0, showing a progressive DNA hypomethylation observed during “speed aging” ex vivo. Moreover, DNA hypomethylation was maximal in skin of the oldest donors (>65yrs), in line with recognized human skin aging characteristics. Topically applied melatonin (200mM) significantly increased epidermal 5-mC, DNMT1, and TET3 protein expression ex vivo after 3 and/or 6 days, compared to vehicle-treated control skin. Interestingly, the 5-mC response to melatonin treatment was most pronounced in “middle-aged” skin, while DNMT1 and TET3 expression changes did not differ between age groups. Our pilot data suggest that global DNA hypomethylation is a fundamental feature of human skin aging, which may promote the overexpression of aging-associated genes and suppress anti-aging genetic programs. The high-dose topical melatonin, which circumvents its rapid metabolism in the liver, penetrates the skin barrier and can counteract DNA hypomethylation ex vivo. This introduces a new mechanism for how melatonin can be utilized to slow human skin aging. Kinga Linowiecka<sup>1, 2, 3</sup>, Jérémy Chéret<sup>2, 3</sup>, Aysun Akhundlu<sup>3</sup>, Yeqin Dai<sup>3</sup>, Jing Jing<sup>3</sup>, Tatiana Gomez-Gomez<sup>3</sup>, Ramtin Kassir<sup>4</sup>, Jennifer Gherardini<sup>2</sup>, Ralf Paus<sup>2, 3</sup> 1. Department of Human Biology, Nicolaus Copernicus University in Torun, Torun, Poland. 2. Cutaneon - Skin & Hair Innovations GmbH, Hamburg & Berlin, Germany. 3. Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, United States. 4. Kassir Plastic Surgery, New York, NY, United States. Epidermal Structure and Barrier Function